Glatiramer acetate
HealthData.Gov
Updated Mar 23, 2026
About this dataset
Glatiramer Acetate is a generic prescription drug manufactured by Mylan Pharmaceuticals Inc., approved under ANDA091646. It's an injectable solution (20 mg/mL) administered subcutaneously for treating multiple sclerosis. Packaged as 30 pre-filled syringes (1 mL each) in a carton. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Glatiramer acetate
Access the FDA dataset for Glatiramer acetate โ ANDA 020622 submitted by Mylan Institutional LLC
Modified Mar 23, 2026